Financial Hardship Common in Patients With Cancer
TUESDAY, Sept. 24, 2024 -- Nearly half of patients with cancer experience some level of financial hardship (FH), according to a study published online Aug. 15 in JCO Oncology Practice.
Betina Yanez, Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues used data from 2,305 participants in the Northwestern University Improving the Management of Symptoms during and following Cancer Treatment trial to examine the longitudinal relationships between financial hardship, anxiety, and depression in patients with cancer.
The researchers found correlations between FH and depressive symptoms (r = 0.310) and anxiety (r = 0.289). Baseline and six-month depressive symptom levels predicted later FH (baseline: β = 0.079; six-month: β = 0.072), and nine-month FH significantly predicted 12-month depressive symptoms (β = 0.083), even after accounting for health care charges and out-of-pocket costs. Baseline and nine-month anxiety predicted subsequent FH (baseline: β = 0.097; nine-month: β = 0.071).
"The psychological toll of financial toxicity or the stress and worry that comes with such financial concerns is particularly distressing for patients who are already going through the difficulties of cancer treatment," coauthor Laila A. Gharzai, M.D., also from Northwestern University, said in a statement. "It is important to screen patients for risk of financial toxicity so that we can better identify those experiencing it and connect them with resources."
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
No Adverse Neurodevelopmental Effects Seen From Inhaled Anesthesia in Children Under 2
THURSDAY, Sept. 11, 2025 -- For children younger than 2 years undergoing surgery, no adverse neurodevelopmental effects are seen with the addition of dexmedetomidine and...
Dementia Odds Significantly Increase With More Psychiatric Comorbidities
WEDNESDAY, Sept. 10, 2025 -- Dementia odds significantly increase with the number of psychiatric comorbidities, according to a study published online Sept. 9 in BMJ Mental...
Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder
WEDNESDAY, Sept. 10, 2025 -- A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.